Abstract
Erythroderma refers to a spectrum of skin diseases resulting in diffuse erythema and scaling encompassing ≥ 90% of the body surface area. The differential diagnosis ranges from primary dermatologic diseases such as atopic dermatitis and psoriasis to potentially deadly causes such as staphylococcal toxic shock syndrome, toxic epidermal necrolysis, and malignancy. Cutaneous T cell lymphoma (CTCL) is an uncommon but highly morbid cause of erythroderma. This non-Hodgkin lymphoma remains a diagnostic challenge due to its variable clinical presentation and varied histologic features. Mycosis fungoides (MF) is the most common form of CTCL. Making a timely diagnosis is challenging as it may mimic inflammatory diseases of the skin including eczema, psoriasis, lichen planus, and cutaneous lupus. We present a case of a 58-year-old man who presented with 5 years of cutaneous symptoms and several months of fevers and night sweats, ultimately diagnosed as MF. Owing to diffuse CD30 positivity, he was a candidate for brentuximab vedotin, an antibody-drug conjugate medication that selectively targets the CD30 antigen. This resulted in an excellent therapeutic response.
References
Feb 1, 1995·The Journal of Clinical Investigation·B A PancakeE E Coutavas
Apr 18, 2000·Archives of Dermatology·R van DoornR Willemze
Oct 19, 2001·Journal of the American Academy of Dermatology·V SigurdssonW A van Vloten
Sep 2, 2005·International Journal of Dermatology·Benmously Mlika RymBen Osman-Dhahri Amel
Nov 29, 2005·Journal of the American Academy of Dermatology·Nicola PimpinelliUNKNOWN International Society for Cutaneous Lymphoma
Jan 18, 2006·Journal of Cutaneous Pathology·Eric C Vonderheid
May 3, 2006·International Journal of Dermatology·F H SakamotoM S Pombo-de-Oliveira
Feb 15, 2007·American Journal of Clinical Dermatology·Shaily PatelJoseph C English
Jul 24, 2008·Blood·Suzanne O ArulogunChristopher McCormack
Sep 10, 2011·Leukemia·T KrejsgaardA Woetmann
Dec 14, 2011·Blood·Marchina F BennerRein Willemze
Jul 23, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R WillemzeUNKNOWN ESMO Guidelines Working Group
Oct 10, 2015·Diagnostic Pathology·Michiko YamashitaTadashi Yoshino
Mar 17, 2017·Anais Brasileiros De Dermatologia·Yara Martins OrtigosaLuciena Cegatto Martins Ortigosa
Jun 11, 2017·Lancet·H Miles PrinceUNKNOWN ALCANZA study group
Feb 2, 2018·Psoriasis : Targets and Therapy·Eckart Haneke